Sutton Wealth Advisors Inc. Ligand Pharmaceuticals Inc Transaction History

Sutton Wealth Advisors Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Nov 07, 2023	SELL	$65.67 - $77.08 $21,145 - $24,819	-322 Closed	0 $0
Q3 2022 Nov 07, 2023	BUY	$0.01 - $107.56 $0 - $107	1 Added 0.31%	322 $27.7 Million
Q1 2022 Nov 07, 2023	BUY	$94.99 - $151.56 $10,353 - $16,520	109 Added 51.42%	321 $36.1 Million
Q4 2021 Nov 07, 2023	SELL	$127.69 - $165.85 $6,639 - $8,624	-52 Reduced 19.7%	212 $32.7 Million
Q3 2021 Nov 07, 2023	BUY	$102.33 - $144.73 $27,015 - $38,208	264 New	264 $36.8 Million
Q4 2018 Nov 06, 2023	SELL	$128.36 - $272.13 $37,609 - $79,734	-293 Closed	0 $0
Q3 2018 Nov 06, 2023	BUY	$211.18 - $274.49 $9,503 - $12,352	45 Added 18.15%	293 $80.4 Million
Q2 2017 Nov 06, 2023	BUY	N/A	41 Added 19.81%	248 $30.1 Million
Q1 2016 Nov 06, 2023	BUY	N/A	207	207 $22.2 Million

257

18.2M

26.8K

9.3K

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.88B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

Get notified when there are updates to the investment portfolio of Sutton Wealth Advisors Inc., based on Form 13F filings with the SEC.

Stay updated on Sutton Wealth Advisors Inc. with notifications on news.